Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00220207 · ClinicalTrials.gov registry record · NA

Determining the Effect on Patients of Internet-Based Diabetes Disease Management

A NA study of Diabetes Mellitus, Type 2, sponsored by Robert Wood Johnson Foundation.

Completed
Registry status
NA
Development phase
63
Enrollment target
1
Study location

NCT00220207 is a NA study of Diabetes Mellitus, Type 2 that has completed, run by Robert Wood Johnson Foundation. The registered enrollment target is 63 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00220207, a NA study of Diabetes Mellitus, Type 2, has completed, sponsored by Robert Wood Johnson Foundation.

COMPLETED
Registry status
NA
Development phase
63 participants
Enrollment target
1
Study location

Study Summary

This grant supports a 12-month randomized controlled trial comparing usual care versus collaborative disease management over the Internet among disadvantaged African-Americans with Type 2 diabetes. The project aims to: (1) determine the effect of case-managed, Web-based diabetes care on glycemic control, health care utilization, self-efficacy, and patient satisfaction; and (2) qualitatively identify enablers of the successful use of computers, the Internet, and e-Health applications by disadvantaged patients.

Conditions Studied

Interventions

  • BEHAVIORAL Internet co-management module

Study Locations (1)

Washington

  • Harborview Medical Center - Seattle

Trial Details

FieldValue
Enrollment Target 63 participants
Start Date 2003-09
Est. Completion 2007-02
Phase NA

Sponsor

Robert Wood Johnson Foundation

14 total trials

What the Registry Record Tells You About NCT00220207

The ClinicalTrials.gov registry entry for NCT00220207 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower). The listed sponsor is Robert Wood Johnson Foundation, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which Internet co-management module is the first listed.

NCT00220207 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT00220207 about?

NCT00220207 is a clinical study titled "Determining the Effect on Patients of Internet-Based Diabetes Disease Management". This grant supports a 12-month randomized controlled trial comparing usual care versus collaborative disease management over the Internet among disadvantaged African-Americans with Type 2 diabetes. The project aims to: (1) determine the effect of case-managed, Web-based diabetes care on glycemic con...

What is the current status of trial NCT00220207?

This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2003-09. Estimated completion is 2007-02.

What conditions does trial NCT00220207 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 2.

What interventions are being tested in trial NCT00220207?

The interventions under investigation include: Internet co-management module (BEHAVIORAL).

Who is sponsoring clinical trial NCT00220207?

This trial is sponsored by Robert Wood Johnson Foundation, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00220207 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus, Type 2

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.